Microelectrode Recordings From the Vagus Nerve in Awake Humans

Sponsor
University of Minnesota (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06016686
Collaborator
(none)
60
2
2
12
30
2.5

Study Details

Study Description

Brief Summary

This Anchillary project uses a refined technique of ultrasound-guided microneurography of the human cervical vagus nerve, an approach developed by Professor Vaughan Macefield and used safely to-date in 44 prior study participants.

The overall goal of this project is to build upon prior data obtained using this approach by undertaking a detailed neurophysiological investigation of the human vagus nerve and to identify the nerve fibers activated during vagal nerve stimulation (VNS) in participants with implanted VNS devices in response to different stimulation parameters. In addition to providing data in unprecedented detail into the physiology of the human vagus nerve, this project will investigate different stimulus intensities, durations and frequencies that differentially excite myelinated and unmyelinated nerve fibers. These results will inform the CSP and guide future development of novel neural interfaces for VNS for various clinical applications.

Condition or Disease Intervention/Treatment Phase
  • Other: VNS stimulation and intraneural recordings
  • Other: Record multi-unit activity from intraneural sites
Phase 1

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Microelectrode Recordings From the Vagus Nerve in Awake Humans
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: VNS

participants with surgically implanted VNS electrodes to treat drug-resistant epilepsy

Other: VNS stimulation and intraneural recordings
A minimum of three stimulation frequencies (1, 10 and 30 Hz), each up to 60s in duration, will be delivered via the VNS device. Intraneural recordings proximal or distal to the VNS electrodes during delivery of VNS will be performed. Approximately two to five fascicles will be explored in each nerve.

Experimental: non-VNS participants

participants without implanted VNS devices

Other: Record multi-unit activity from intraneural sites
Perform a more detailed vagal nerve mapping study by recording from single nerve fibers, including those fibers supplying the heart, lungs, airways and other end-organs. The investigators shall perform functional mapping of the left and right vagus nerves, such as those with cardiac-related and/or respiratory-related neural activity. The research team will also record activity from other nearby fibers to map the differences in neurological behavior in fascicles that control the heart, lungs, airways and other systems.

Outcome Measures

Primary Outcome Measures

  1. identify action potential morphology of specific fibers activated by vagal nerve stimulation (VNS) [4 hours]

    assessing vagal nerve activity in epilepsy participants during and in the absence of stimulation. Labchart; spike histogram module

  2. identify ratio of myelinated fibers in specific fibers activated by vagal nerve stimulation (VNS) [4 hours]

    assessing vagal nerve activity in epilepsy participants during and in the absence of stimulation. Labchart; spike histogram module. Whether a nerve fiber is (un)myelinated can be determined by visual inspection. Myelinated fibers typically produce "a positive-going narrow spike profile.

  3. physiological identification of the specific fibers activated by vagal nerve stimulation (VNS) [4 hours]

    assessing vagal nerve activity in epilepsy participants during and in the absence of stimulation. Labchart; spike histogram module. use of tracing and nerve recordings analysis to identify the types of nerves

  4. identify firing rates of the specific fibers activated by vagal nerve stimulation (VNS) [4 hours]

    assessing vagal nerve activity in epilepsy participants during and in the absence of stimulation. Labchart; spike histogram module. in Hertz

  5. identify stimulus current required to activate specific fibers activated by vagal nerve stimulation (VNS) [4 hours]

    assessing vagal nerve activity in epilepsy participants during and in the absence of stimulation. Labchart; spike histogram module. in milli-amps

  6. differences in firing rates of cardiac parasympathetic vagal activity [4 hours]

    compare any changes in parasympathetic vagal activity with participants who have not been implanted with a vagal nerve stimulator (Non-VNS Participants). Labchart; spike histogram module. Unit: Hz.

  7. Discharge variability of cardiac parasympathetic nerve fibers [4 hours]

    Vagal nerve stimulator device. Coefficient of variation, %

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • The participant is greater than or equal to (≥)18 years and is less than or equal to (≤) 40 years of age

  • English speaking

  • Medicare covered or equivalent health insurance from a partner country

Exclusion Criteria:
  • Pregnant

  • Smokes and is unwilling to abstain from smoking on the day of the experiment.

  • Inability or unwillingness to provide written informed consent.

  • Individuals with difficulty standing unassisted for 5 minutes during the tilt-table testing

  • Individuals found to have a significant carotid artery plaque or intima-media thickness > 1 mm as assessed by ultrasonography during the ultrasound-screening steps of the study visit

  • Vagus nerve not visible on ultrasound

  • VNS electrodes are not in a suitable location to allow for microelectrode insertion

  • Any other clinical reasons deemed by the investigators

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Minnesota Minneapolis Minnesota United States 55455
2 99 Commercial Road Prahan Victoria Australia 3182

Sponsors and Collaborators

  • University of Minnesota

Investigators

  • Principal Investigator: Vaughan G Macefield, PhD, Monash University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT06016686
Other Study ID Numbers:
  • VNS
First Posted:
Aug 30, 2023
Last Update Posted:
Aug 30, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 30, 2023